A new therapeutic option for human hepatocyte cancer
p53-impaired tumors may be particularly suitable to parvovirus H-1-induced therapy. Although the p53 deficiency in tumors may induce resistance to chemotherapeutic agents, this will not affect the tumor cell susceptibility to H-1 PV-induced oncolytic infections. The parvovirus H-1 may also overcome other tumor resistance mechanisms developed in these tumor entities. So H-1 PV is a suitable agent to circumvent the resistance of p53-negative human hepatocellular carcinoma (HCC) cells to genotoxic agents, and enhances the apoptotic process which is dependent on functional PML. Thus, H-1 PV may be considered as therapeutic options for HCC, especially for p53-negative tumors. The research team led by Prof. Markus Moehler from First Department of Internal Medicine of Johannes Gutenberg University of Mainz evaluated the synergistic targeting and killing of human HCC cells lacking p53 by the oncolytic autonomous PV H-1 with chemotherapeutic agents. This was published on 28 June 2008, in the World Journal of Gastroenterology.
Their result shows that parvovirus H-1 PV triggers an apoptotic type of death in human HCC cells, and that p53 is dispensable for this process. In contrast, PML, which is induced by H-1 PV infection, helps the parvovirus to kill the carcinoma cells, irrespective of their p53 status. Given the known dependence of apoptosis induction by radio-chemotherapeutic agents on the p53 status of target cells, parvoviruses appear to be suitable adjuvants to eliminate tumor cell populations with resistance against these agents by means of combined treatments. Parvovirus H-1 will be a new option for patients with human HCC and clinical phase I-II trials with these oncolytic gene therapy vectors should be done in the near future.
Many viruses are known to be pathogenic and increase carcinogenesis. In the contrary, the autonomous parvoviruses destroy tumors, activate the immune system and may thus even be good for the health of men.
Source: World Journal of Gastroenterology
Related
- Bacterial peptide provides new insight into common tumor suppressorMon, 7 Jul 2008, 12:42:52 EDT
- Tumor-inhibiting protein could be effective in treating leukemiaTue, 15 Jul 2008, 6:08:12 EDT
- Experimental anti-cancer synthetic molecule targets tumor cell growth and angiogenesisWed, 18 Jun 2008, 8:07:38 EDT
- Brain tumor treatment may increase number of cancer stem-like cellsThu, 5 Mar 2009, 12:39:05 EST
- A potent and selective anti-tumor agent on human gastric adenocarcinomaMon, 20 Apr 2009, 11:23:46 EDT
Other sources
- A new therapeutic option for human hepatocyte cancerfrom PhysorgTue, 23 Sep 2008, 9:49:40 EDT
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Generating electricity from air flow
- Therapy 32 times more cost effective at increasing happiness than money
- Beyond genomics, biologists and engineers decode the next frontier
- It's a gas: New discovery may lead to heartier, high-yielding plants
- Therapy 32 times more cost effective at increasing happiness than money
- Full recovery now possible for an 'untreatable' mental illness
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Is global warming unstoppable?
- Polyphenols and polyunsaturated fatty acids boost the birth of new neurons
- New evidence that dark chocolate helps ease emotional stress
- African desert rift confirmed as new ocean in the making
- Scientists discover influenza's Achilles heel: Antioxidants
- Nanoparticles used in common household items caused genetic damage in mice
- Therapy 32 times more cost effective at increasing happiness than money